AKBA is currently covered by 4 analysts with an average potential upside of $6.4 (88.32%) backed by displayed 50 price targets and 59 ratings.
Analysts average stock forecasts to be materialized ratio is 41.39% with an average time for these price targets to be met of 153.82 days.
Highest price target for AKBA is 2, Lowest price target is 1, average price target is 1.5. For detailed individual stock analysts price targets on AKBA go to the chart section.
Most recent stock forecast was given by ED ARCE from HCWAINWRIGHT on 26-May-2023. First documented stock forecast 14-May-2015.
Currently, out of the existing stock ratings of AKBA - 4 which are a Buy (36.36%), 7 which are a Hold (63.64%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
2
$0.87 (76.99%)
2
4 days ago
3/6 (50%)
$0.8 (100.98%)
72
Buy
7
1 years 1 months 29 days ago
3/6 (50%)
$5.37 (107.92%)
411
Hold
26
1 years 1 months 29 days ago
0/2 (0%)
$14.43 (108.46%)
Hold
8
1 years 1 months 29 days ago
0/10 (0%)
$7.72 (108.16%)
Hold
3
1 years 6 months 25 days ago
4/4 (100%)
$0.09 (3.79%)
27
What is AKBA(Akebia Therapeutics, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on AKBA(Akebia Therapeutics, Inc) with a proven track record?
